In this retrospective study, we developed individualized nomograms integrating 18F-FDG PET/CT radiomics, radiological and clinical features to provide a non-invasive approach to predict EGFR mutation status in NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.